Research ArticleCANCER TREATMENT

CHK1 as a therapeutic target to bypass chemoresistance in AML

See allHide authors and affiliations

Science Signaling  13 Sep 2016:
Vol. 9, Issue 445, pp. ra90
DOI: 10.1126/scisignal.aac9704

Article Information

vol. 9 no. 445 ra90

PubMed: 
Published By: 
Print ISSN: 
Online ISSN: 
History: 
  • Received July 7, 2015
  • Accepted August 26, 2016
  • .

Author Information

Altmetric

Article usage

Article usage: September 2016 to April 2020

AbstractFullPdf
Sep 20165002166399
Oct 20165365694
Nov 20162462939
Dec 20161272519
Jan 20171281414
Feb 20171741637
Mar 20171171625
Apr 201799714
May 201783912
Jun 201779915
Jul 201766414
Aug 201789512
Sep 20178289
Oct 20176049
Nov 201788510
Dec 201779517
Jan 201869413
Feb 201880814
Mar 20185765
Apr 20188198
May 201889517
Jun 201875510
Jul 20187158
Aug 2018542314
Sep 2018712210
Oct 2018752713
Nov 2018122238
Dec 201872157
Jan 2019662810
Feb 2019572210
Mar 201962195
Apr 201933167
May 2019471613
Jun 20192888
Jul 201942133
Aug 201943146
Sep 201933178
Oct 201934159
Nov 2019422115
Dec 20194354
Jan 2020591810
Feb 202040109
Mar 20204265
Apr 2020100

Stay Connected to Science Signaling


Editor's Blog